A recent Report of the Council on Pharmacy and Chemistry of the American Medical Association1 indicated that creosote and its allied preparations have received more promotion and widespread application in the past than is warranted by the available pharmacologic evidence. The Council found little published scientific evidence to substantiate claims of some drug firms for the value of these compounds in the treatment of various pulmonary conditions. Before reaching a final decision the Council sent a questionnaire to members of the Association of American Physicians and the American Pediatric Society. The result of this survey confirmed the Council's conclusions and indicated that such drugs are rarely employed by leaders in the profession and that their rationale is little understood by those who do employ them. The Council omitted all such preparations from New and Nonofficial Remedies because they are marketed without satisfactory evidence that they have sufficient therapeutic value
CRITICAL CREOSOTE CRITERIA. JAMA. 1939;113(20):1815. doi:10.1001/jama.1939.02800450037013
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: